Entrepreneurs Investment Meet

The life sciences sector’s growth correlates highly with countries’ general economic strength and health care spending levels, and both of these vary widely around the globe. In 2015 North America accounted for 48.7% of world pharmaceutical sales compared with 22.2% for Europe. According to IMS Health data, 58% of sales of new drug discovery made during the period 2010–2015 were on the US market, compared with 23% on the European market. Europe is ensuring competitive growth along with other countries.  By 2022, products currently in drug development will account for 17% of sales in Europe. Europe is expected to show a 3% CAGR 2016-22, mainly driven by the launch of new products currently in development. The penetration of biotech products is set to increase from a 24% market share in 2015 to 29% in 2022.

    Related Conference of Entrepreneurs Investment Meet

    June 06-07, 2018

    International Conference & B2B on Pharma Research and Development

    Philadelphia, Pennsylvania, USA
    June 08-09, 2018

    8th International Conference and Exhibition on GMP, GCP & Quality Control

    Philadelphia, Pennsylvania, USA
    June 08-09, 2018

    7th International conference on Pharmaceutical Auditing

    Philadelphia, Pennsylvania, USA
    June 27-28, 2018

    4th International Conference on Drug Discovery, Designing and Development

    Vancouver, British Columbia, Canada
    August 20-21, 2018

    12th Asian Biologics and Biosimilars Congress

    Tokyo, Japan
    October 18-19, 2018

    18th World Pharma Congress

    Warsaw, Poland
    November 15-16, 2018

    14th International Conference on Generic Drugs and Biosimilars

    Frankfurt, Germany
    September 18-19, 2018

    6 th European Biopharma Congress

    Amsterdam, Netherlands

    Entrepreneurs Investment Meet Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in